New Delhi, November 3, 2025 — India is witnessing a concerning surge in gynaecological cancers, including cervical, ovarian, and uterine cancers, with over 2 lakh new cases reported annually. Experts warn that while medical advancements are improving treatment options, lack of awareness and delayed diagnosis continue to hinder outcomes for thousands of women.
According to GLOBOCAN 2022 data, gynaecological cancers now account for a significant portion of the 7 lakh cancer cases reported among Indian women each year. Cervical cancer alone causes approximately 77,000 deaths annually, and ovarian cancer — often detected at advanced stages — has a survival rate below 50%.
Health professionals emphasize that awareness beyond medicine is essential. “We need to normalize conversations around women’s health, encourage routine screenings, and educate communities about symptoms and risk factors,” said Dr. Rakesh Chopra, Chairman of the Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC).
RGCON 2025, the 23rd Annual International Conference on gynaecological cancers, highlighted the urgent need for preventive strategies, innovative treatments, and collaborative efforts across public health, education, and technology sectors.
Advocates are calling for nationwide campaigns to promote HPV vaccination, regular Pap smears, and accessible care for underserved populations. Bridging the gap between medical innovation and public understanding is key to reversing the trend and empowering women to take charge of their health.
